Home » Topics » Regulatory

Regulatory
RSS

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

Lyrica approved in E.U.

July 12, 2004

Eisai launches Apnission in Japan

July 6, 2004

Arava approved in Europe for active psoriatic arthritis

July 2, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

Biovail's NDA for novel dosage form of citalopram accepted for review

June 16, 2004

FDA approves Vidaza for treatment of MDS

May 24, 2004

FDA approves DepoDur for treatment of pain

May 21, 2004

New approval for Enbrel in psoriasis

May 5, 2004

New indication and strength approved for Hectorol

April 29, 2004